Oncogene 22, 797-806CrossRefGoogle Scholar 85Morito, N., Yoh, K., Itoh, K
Augmenting L-cell GLP-1 secretion By doubling meal-related responses of intact, biologically active GLP-1, DPP-4 inhibitors exert profound effects on glycaemic control in patients with type 2 diabetes

AD: Alzheimers disease cAMP: cyclic adenosine monophosphate CSF: cerebrospinal fluid DPP-4: dipeptidyl-peptidase 4 DR: diabetic retinopathy GFAP: glial fibrillary acidic protein GLP-1: glucagon-like peptide 1 GLP-1R: glucagon-like peptide 1 receptor GLP-1RA: glucagon-like peptide 1 receptor agonist IIH: idiopathic intracranial hypertension IL-1beta: interleukin 1 beta NF-B: nuclear factor kappa B NO: nitric oxide PD: Parkinsons disease PINK1: protein phosphatase and tensin homolog-induced kinase 1 PKA: protein kinase A PPG: preproglucagon RGCs: retinal ganglion cells RPE: retinal pigment epithelium T2DM: type 2 diabetes mellitus TNF-alpha: tumor necrosis factor alpha VEGF: vascular endothelial growth factor Sohum S, AP, MF, MM, AR, RS, and Siddharth S: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writingoriginal draft

This article will unpack the concept of C-rate, explain what 2C really means, and help you apply this knowledge when selecting or configuring batteries for any high-demand device
l-carnitine in critically ill patientsa case series study